Cool Chain

Kuehne + Nagel to open pharma logistics hub in Chile

Swiss freight forwarder Kuehne + Nagel is to open a new logistics hub this summer in Santiago, Chile to meet demand from the growing pharma and healthcare industry in South America.

As of August, the forwarder will offer customers a dedicated pharma warehouse and it said it provides its global KN PharmaChain network, the multi-modal logistics solution for temperature-controlled door-to-door transportation, with an enhanced regional footprint.

The new facility it added further underlines Kuehne + Nagel’s continuous commitment to expand its GXP compliant warehousing and forwarding services worldwide.

While eco-friendly built and equipped, the logistics hub complies with the highest security standards and state-of-the-art technology to increase current operational capacities.

The facility will provide an area of 17,600 square metres for storage and distribution of temperature-sensitive products, which can be extended to 23,300 square metres, including a cold chamber to handle temperature requirements of 15 to 25 degrees Celsius and 2 to 8 degrees Celsius.

A renewed laboratory for quality control allows customers to comply with the regulatory requirement to carry out local analysis of imported pharmaceutical products. Additionally, GMP compliant repackaging and relabelling areas following Chilean and international specifications will be available as value added services.

The hub will use clean energy via a geothermal system to keep the temperature of its general area between 15 to 25 degrees Celsius.

Kuehne + Nagel president for South & Central America, Ingo Goldhammer said: “With more than 40 years demonstrating commitment to the Chilean market, this cutting-edge facility will leverage the knowledge and experience of our specialised teams and enable Kuehne + Nagel to offer its unique pharma solutions to an extended customer base.

“This investment is in line with our strategic ongoing commitment to the pharma & healthcare industry globally strengthening our position as a leading player in pharma logistics.”